Can immunomodulatory therapies effectively target neuroinflammation in familial FTD?

OPEN

The authors suggest neuroinflammation warrants consideration of immunomodulatory therapies but provide no evidence for therapeutic efficacy. This represents a critical translational gap for disease modification strategies. Gap type: open_question Source paper: In vivo PET imaging of neuroinflammation in familial frontotemporal dementia. (2021, Journal of neurology, neurosurgery, and psychiatry, PMID:33122395)

Priority: 0.79 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Can immunomodulatory therapies effectively target neuroinflammation in familial FTD? is a 0.79 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Can immunomodulatory therapies effectively target neuroinflammation in familial FTD? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (2)

ALSFTDLC3FTD

associated with (23)

PARKINSON'S DISEASEFTDALZHEIMER'S DISEASEFTDTARDBPFTDALSFTDTAUFTD
▸ Show 18 more

biomarker for (2)

Tau 3R/4R RatioFTDCryptic Hdgfl2FTD

causes (7)

ALSFTDTARDBPFTDTDP-43FTDC9ORF72FTDC9ORF72 REPEAT RNAFTD
▸ Show 2 more

contributes to (2)

Rbp DysfunctionFTDstress_granule_formationFTD

cross disease mechanism in (5)

TARDBPFTDC9ORF72FTDMAPTFTDTIA1FTDTBK1FTD

implicated in (1)

G3BP1FTD

interacts with (3)

ALSFTDFTDLRRK2FTDNEURONS

regulates (1)

ALSFTD

risk factor for (4)

C9orf72 expansionsFTDGgggcc Repeat ExpansionFTDC9orf72 HREFTDTBK1FTD
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps